The Association between Adiponectin/Leptin Ratio and Diabetes Type: The SEARCH for Diabetes in Youth Study - 07/08/11
Doi : 10.1016/j.jpeds.2008.12.048
David M. Maahs, MD a, ⁎ 
, Richard F. Hamman, MD, DrPH a, Ralph D’Agostino, PhD b, Lawrence M. Dolan, MD c, Guiseppina Imperatore, MD, PhD d, Jean M. Lawrence, ScD, MPH, MSSA e, Santica M. Marcovina, PhD f, Elizabeth J. Mayer-Davis, PhD g, Catherine Pihoker, MD h, Dana Dabelea, MD, PhD a
, Richard F. Hamman, MD, DrPH a, Ralph D’Agostino, PhD b, Lawrence M. Dolan, MD c, Guiseppina Imperatore, MD, PhD d, Jean M. Lawrence, ScD, MPH, MSSA e, Santica M. Marcovina, PhD f, Elizabeth J. Mayer-Davis, PhD g, Catherine Pihoker, MD h, Dana Dabelea, MD, PhD a a Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Denver, CO
b Wake Forest University School of Medicine, Winston-Salem, NC
c Cincinnati Children’s Hospital, Cincinnati, OH
d Centers for Disease Control and Prevention, Atlanta, GA
e Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA
f Northwest Lipid Research Laboratory, Seattle, WA
g University of South Carolina School of Public Health, Columbia, SC
h Children’s Hospital and Regional Medical Center, Seattle, WA
Reprint requests: David M. Maahs, MD, University of Colorado Health Sciences Center, The Barbara Davis Center for Childhood Diabetes, PO Box 6511, Mail Stop A140, Aurora, CO80045.Abstract |
We tested the association of adiponectin/leptin ratio with diabetes type after adjusting for multiple factors in 1156 youths with newly diagnosed diabetes in the SEARCH study. Although adiponectin/leptin ratio is associated with diabetes type in youth, it is due to differences in adiponectin, but not leptin levels
Le texte complet de cet article est disponible en PDF.Mots-clés : ALR, BMI
Plan
| Funding information available at www.jpeds.com (Appendix). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. The study sponsors have had no involvement in this study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication. |
© 2009
Mosby, Inc. Tous droits réservés.
Vol 155 - N° 1
P. 133 - juillet 2009 Retour au numéro
Article précédent
- A Randomized Controlled Trial to Evaluate the Efficacy of Lactobacillus GG in Infantile Diarrhea
- Sudipta Misra, Tapas K. Sabui, Nishith K. Pal
- Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura
- Katherine J. Donnithorne, T. Prescott Atkinson, Claas H. Hinze, Janaina B. Nogueira, Shehzad A. Saeed, David J. Askenazi, Timothy Beukelman, Randy Q. Cron
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?